Lead engineer at an early-stage endovascular medical device startup developing thrombectomy devices for acute deep venous thrombosis. Primary engineering authority within the organization; work directly informed $2M in grant funding and $4.2M in seed financing, with ongoing Series A interest from a top-five global medical device company.
- Translated engineering progress, test data, and technical risk into board and investor materials; served as the engineering point of contact for investor due diligence; advised leadership on technical strategy.
- Led the engineering side of IP strategy: translated device concepts and test results into defensible patent filings, owned technical documentation, worked directly with outside counsel.
- Designed a novel experimental protocol and built the custom imaging and analysis system to quantify clot fragmentation in candidate thrombectomy devices. Replaced a flawed filter-based method; improved data integrity; enabled rapid iteration before pivotal animal studies.
- Designed and delivered a functional catheter aspiration system on a one-month deadline tied to scheduled animal studies; integrated off-the-shelf components with custom SolidWorks hardware.
- Spearheaded concept, prototypes, and IP for a modular multi-tool thrombectomy platform addressing diverse clot morphologies; progress reinforced ongoing Series A interest.
- Served as Caeli-side technical lead on a development relationship with an external contract engineering firm, coordinating device- and component-level work and integrating their output into Caeli's development program.
- Operated within an ISO 13485–compliant quality management system, requiring adherence to structured design controls and documentation practices.